<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02756741</url>
  </required_header>
  <id_info>
    <org_study_id>AIIMS sbp</org_study_id>
    <nct_id>NCT02756741</nct_id>
  </id_info>
  <brief_title>Comparison of Standard Dose Versus Once a Day Intravenous Albumin in Spontaneous Bacterial Peritonitis</brief_title>
  <official_title>Assessment of Cytokine Profile in an Open Labeled Randomized Controlled Trial of Standard Dose vs. Once a Day Intravenous Albumin in Patients With Spontaneous Bacterial Peritonitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>All India Institute of Medical Sciences, New Delhi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>All India Institute of Medical Sciences, New Delhi</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The standard recommended management of spontaneous bacterial peritonitis (SBP) includes a
      third-generation cephalosporin (cefotaxime or ceftriaxone) and high dose albumin (1.5g/kg on
      day 1 and 1g/kg on day 3). The major drawback of the current recommendations is the high
      price of albumin. In the current randomized control trial investigators compared the effect
      of standard recommended dose of albumin (1.5g/kg on day 1 and 1g/kg on day 3) vs. low dose
      (20g/d for 5 days) on the resolution of SBP and subsequent cytokine changes in ascitic fluid
      and blood.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in neutrophils/mm in ascitic fluid</measure>
    <time_frame>3 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in IL-6, IL-1, TNF in ascitic fluid and serum between the two groups</measure>
    <time_frame>5 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Survival in days at the end of therapy</measure>
    <time_frame>5 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differences in frequency of sepsis, renal failure and other organ failures between the two groups</measure>
    <time_frame>5 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Cirrhosis</condition>
  <arm_group>
    <arm_group_label>STANDARD DOSE</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Albumin 1.5gm/kg on day 1 and 1gm/kg on day 3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LOW DOSE</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Albumin 20g/d for 5 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ALBUMIN</intervention_name>
    <description>Albumin in two different doses</description>
    <arm_group_label>STANDARD DOSE</arm_group_label>
    <arm_group_label>LOW DOSE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Diagnosis of SBP

          2. Age &gt; 18 years

          3. Consent to participate in the trial

        Exclusion Criteria:

          1. Secondary peritonitis

          2. Malignancies including HCC
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 24, 2016</study_first_submitted>
  <study_first_submitted_qc>April 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2016</study_first_posted>
  <last_update_submitted>April 27, 2016</last_update_submitted>
  <last_update_submitted_qc>April 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>All India Institute of Medical Sciences, New Delhi</investigator_affiliation>
    <investigator_full_name>Subrat Kumar Acharya</investigator_full_name>
    <investigator_title>Professor and Head, Department of Gastroenterology</investigator_title>
  </responsible_party>
  <keyword>Cirrhosis</keyword>
  <keyword>hepatitis B virus</keyword>
  <keyword>Alcohol</keyword>
  <keyword>varices</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Peritonitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

